生长激素促分泌剂 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
In the scientific literature, ipamorelin appears mainly in preclinical studies, receptor binding assays, and reviews of growth hormone secretagogues. Authors often discuss its selectivity profile alongside limitations such as small sample sizes, short study durations, and differences between species. Some papers examine pharmacokinetics and clearance, but human data are limited and not sufficient to define general clinical effects. Regulatory discussion treats the compound as an investigational or research substance rather than an approved therapy in most jurisdictions. Open questions include oral bioavailability, long-term endocrine effects, and whether selectivity observed in animals persists in humans.
Research peptides such as ipamorelin are commonly supplied as lyophilized powder and characterized by analytical certificates. Reversed-phase high-performance liquid chromatography is used to estimate purity by ultraviolet absorbance, while mass spectrometry confirms molecular identity and detects sequence-related impurities. Counterion content, water content, and residual synthesis reagents can affect the reported mass balance. A certificate of analysis may list a purity percentage, but that number depends on the analytical method and the definition of impurity peaks. Independent verification is often recommended because research supply chains vary in quality control practices.
Storage recommendations for ipamorelin usually focus on temperature, moisture, and light. Lyophilized powder is typically held at or below minus twenty degrees Celsius in a desiccated container protected from light. Reconstituted solutions are often aliquoted and stored at minus eighty degrees Celsius to reduce repeated freeze-thaw cycles, which can promote aggregation or degradation. The optimal buffer and pH depend on the specific assay, and no single condition applies to every experimental context. Peptide stability should be assessed with time-point measurements rather than assumed from general handling rules.
Reversed-phase high-performance liquid chromatography is the standard tool for assessing purity. Detection near 214 nanometers captures the peptide backbone, and the resulting chromatogram shows the main peak alongside related impurities. Electrospray ionization mass spectrometry confirms molecular mass and supports sequence verification. Common degradation products include oxidized residues, deamidated forms, and truncated fragments, each appearing as a distinct peak or shoulder in the trace.
Quality claims for research peptides vary widely across suppliers. A certificate of analysis should list purity by chromatography, the mass found by spectrometry, and the analytical conditions used. Independent testing at a third-party laboratory is a common way to check identity and purity, because documents alone cannot confirm what is inside a vial. Purity figures describe the proportion of the target peptide among detected species, and they say nothing about biological activity or sterility.
Lyophilized ipamorelin powder is the form usually supplied for laboratory work. Kept dry, protected from light, and held at minus 20 degrees Celsius or below, it remains stable for extended periods, often measured in years. Once dissolved, the peptide degrades faster through hydrolysis, oxidation, and deamidation, so solutions are typically refrigerated and used within weeks. Repeated freeze-thaw cycles and exposure to alkaline conditions accelerate loss of the parent compound.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility class | Soluble in water and aqueous buffers | Solubility can depend on pH and salt form |
| Typical storage temperature | −20 °C or lower, desiccated | Protect from light and moisture |
| Typical analytical method | RP-HPLC with UV detection; LC-MS | Identity and purity assessment |
| Common salt form | Acetate salt | Frequently used in research supply |
Ipamorelin 是一种合成五肽，在 20 世纪 90 年代被报道为生长激素促分泌剂。其结构基于胃饥饿素受体激动剂的设计思路，但并非天然激素。早期药理学研究显示，它可刺激垂体释放生长激素，而对应激激素轴的影响相对较小。该化合物常被用作研究生长激素调节通路的工具分子。
在机制层面，ipamorelin 与生长激素促分泌受体 1a 型结合，该受体也介导胃饥饿素的多种效应。受体激活后，细胞内信号促进生长激素从垂体前叶释放。由于对促肾上腺皮质激素和皮质醇的刺激较弱，它被视为选择性较高的促分泌剂。这种选择性在动物模型和少量人体研究中被观察到，但人体数据仍然有限。
At the cellular level, ipamorelin binds the growth hormone secretagogue receptor, also called the ghrelin receptor. Activation of this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to release of growth hormone into circulation. Because release follows a pulsatile pattern, studies often report peak concentration and total area under the curve rather than a single time point. Selectivity for this receptor is the property most frequently discussed in comparative work.
Compared with older secretagogues such as hexarelin or GHRP-6, ipamorelin shows weaker stimulation of cortisol, prolactin, and appetite in the animal models used for early characterization. Whether that selectivity is preserved across longer human exposures remains an open question, because published clinical data are limited in size and duration. Reported effects on food intake are generally described as modest. The compound is therefore treated in the literature as a relatively selective research tool rather than a fully characterized therapeutic agent.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Researchers at a pharmaceutical company first described it in the 1990s while screening small peptides for growth hormone releasing activity. Its chain contains five amino acid residues, two of which are non-natural building blocks, including 2-aminoisobutyric acid and a naphthylalanine derivative. The molecule was designed to act at the ghrelin receptor while avoiding several effects observed with earlier secretagogues.
Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Lyophilized ipamorelin is generally held at minus twenty degrees Celsius or colder, protected from light and moisture. In solution the peptide is less stable, and degradation proceeds through hydrolysis of the amide backbone, oxidation of the histidine residue, and aggregation. Repeated freeze-thaw cycles accelerate these processes, so dividing material into single-use aliquots before freezing is common practice in research settings. Buffered formulations near neutral pH tend to show the slowest degradation, while strongly acidic or basic conditions raise hydrolysis rates. Stability data specific to ipamorelin are sparse, and much guidance is extrapolated from other short peptides.
Quality control for research-grade ipamorelin is not governed by a single harmonized pharmacopeial monograph, so certificates of analysis vary between suppliers. Common tests include appearance, solubility, water content, peptide content by quantitative amino acid analysis, and residual counterion measurement. Independent verification by an outside laboratory is often used to confirm identity and purity claims. Salt form, counterion content, and residual solvent levels are frequently unspecified, which complicates direct comparison between lots and leaves reproducibility partly unresolved.
Identity and purity assessment of ipamorelin relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength where the peptide backbone absorbs. Mass confirmation is typically obtained by electrospray ionization mass spectrometry or by liquid chromatography coupled to mass spectrometry, comparing the observed mass with the calculated value. Amino acid analysis and peptide mapping after enzymatic digestion can confirm the sequence. Impurity profiles include deletion peptides, truncated fragments, and oxidation products, reported as relative area percentages.
== Literatur == M. L. Augee: Platypus and Echidnas. The Royal Zoological Society, New South Wales 1992, ISBN 0-9599951-6-1. Ronald Strahan: Mammals of Australia. Smithsonian Press, Washington DC 1996, ISBN 1-56098-673-5. N. G. Taylor, P. R. Manger, J. D. Pettigrew, L. S. Hall: Electromagnetic potentials of a variety of platypus prey items: an amplitude and frequency analysis. In: L. M. Augee: Platypus and Echidnas. 1992, ISBN 0-9599951-6-1, S. 216–224. T. R. Grant: Fauna of Australia. 16. Ornithorhynchidae Onlinepublikation als PDF (Memento vom 9. November 2006 im Internet Archive) Walter Fiedler (Hrsg.): Säugetiere. In: Grzimeks Tierleben. Band 10, Droemer Knaur, München 1967 (Bechtermünz, Augsburg 2000, ISBN 3-8289-1603-1). Ann Moyal: Platypus. The Extraordinary Story of How a Curious Creature Baffled the World. Smithsonian Press, Washington DC 2001, ISBN 1-56098-977-7. Ulrich Zeller: Die Entwicklung und Morphologie des Schädels von Ornithorhynchus anatinus. (Mammalia: Prototheria: Monotremata), In: Senckenbergische Naturforschende Gesellschaft: Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft. Band 545, Kramer, Frankfurt am Main 1989, ISBN 3-7829-2548-3 (zugleich Habilitationsschrift an der Georg-August-Universität Göttingen). Michael Ohl: Expeditionen zu den Ersten ihrer Art. Außergewöhnliche Tiere und die Geschichte ihrer Entdeckung. dtv, München 2022, ISBN 978-3-423-29043-2, S. 146–167.
Fauna of Australia – Ornithorhynchidae. Von T. R. Grant. In: Australian Biological Resources Study (ABRS). Monografie (englisch) als PDF-Datei Bericht über die Geschlechtschromosomen (englisch) Schematische Darstellung der Giftsporne Artikel in der FAZ-Sonntagszeitung zur Entdeckungsgeschichte des Schnabeltiers Schnabeltier-Genom offengelegt (Pressemitteilung der Uni Münster) Ornithorhynchus anatinus in der Roten Liste gefährdeter Arten der IUCN 2012. Eingestellt von: D. Lunney, C. Dickman, P. Copley, T. Grant, S. Munks, F. Carrick, M. Serena und M. Ellis, 2008. Abgerufen am 27. Oktober 2012. Margarete Blümel: Das Schnabeltier – Säuger, Vogel, Reptil Bayern 2 Radiowissen. Ausstrahlung am 8. Januar 2021 (Podcast)
== Aufbau und Wirkungsweise == Die chemische Struktur der Opioidpeptide ist recht unterschiedlich. Die Peptidketten bestehen aus fünf (Enkephaline) bis 31 Aminosäuren (beta-Endorphin). Die gefalteten Strukturen haben eine große Ähnlichkeit mit dem Opiumalkaloid Morphin. Der endständige Parahydroxyphenylrest des Tyrosins ist beispielsweise dem aromatischen Ring des Morphins ähnlich. Die Aminosäuresequenzen der Opioidpeptide wechselwirken mit den gleichen Rezeptoren wie die exogenen Opiumalkaloide. Ein wesentlicher Unterschied ist, dass die endogenen Opioidpeptide sofort nach ihrer Synthese wieder durch Aminopeptidasen abgebaut werden. Tachyphylaxie und Abhängigkeitsentwicklung werden so verhindert. Die Opioidpeptide binden an den µ1-Opioidrezeptor. Opioidpeptide sind in eine Vielzahl von biologischen Prozessen als Transmitter involviert. Allein oder zusammen mit anderen Transmittersystemen steuern sie physiologische Prozesse.
== Einteilung der Opioidpeptide == Es gibt drei Hauptfamilien endogener Opioidpeptide: die Enkephaline, die Endorphine und die Dynorphine. Diese drei Opioidpeptide werden beim Menschen von drei homologen Genen kodiert. Jedes dieser Gene kodiert ein großes Protein, das in kleinere Einheiten – die eigentlichen Opioidpeptide – zerlegt wird.
Sources: de.wikipedia.org
Purity is commonly estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection. Mass spectrometry is used to confirm identity and to detect sequence-related impurities. Reported percentages depend on the method and the impurity threshold used.
Lyophilized powder is usually kept frozen, desiccated, and protected from light. Reconstituted solutions are often divided into aliquots and stored at very low temperature to limit freeze-thaw cycles. Specific conditions should follow the supplier's certificate of analysis and the assay requirements.
Much of the evidence comes from animal models and cell-based assays rather than large human trials. Small sample sizes, short follow-up, and differences in dosing or route make comparisons difficult. Questions about long-term effects and human relevance remain open.
Keep the powder dry, protected from light, and at minus 20 degrees Celsius or lower. A desiccant and a sealed vial limit moisture uptake. Let the vial reach room temperature before opening to reduce condensation.